Pamrevlumab for IPF, Dapagliflozin in Critical Illness, Payer Involvement in Evidence Generation, and more
Aug 6, 2024
10:39
Episode Description
Editor's Summary by Mary McGrae McDermott, MD, Deputy Editor of JAMA, the Journal of the American Medical Association, for the August 6, 2024, issue.
Proudly Supported by
